Skip to main content

Table 4 Levels of circulating miRNAs in patients with diabetes receiving aspirin, clopidogrel or prasugrel. Values shown are mean ± SD. P values were generated by one-way repeated measures ANOVA with Greenhouse–Geisser correction

From: Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels

miR

2−(ΔΔCq) (mean ± SD)

p

Partial η2 (effect size)

Aspirin

Clopidogrel

Prasugrel

21

1.21 ± 0.67

1.04 ± 0.51

1.03 ± 0.47

0.028

0.065

24

1.05 ± 0.64

0.88 ± 0.70

0.75 ± 0.40

0.009

0.084

27b

1.09 ± 0.79

0.96 ± 1.22

0.75 ± 0.38

0.115

0.042

28

0.83 ± 0.54

0.65 ± 0.53

0.63 ± 0.60

0.083

0.046

93

1.06 ± 0.60

0.95 ± 0.74

1.01 ± 0.78

0.662

0.007

122

0.93 ± 0.82

0.98 ± 0.98

1.07 ± 1.00

0.278

0.023

126

0.93 ± 0.42

0.83 ± 0.47

0.80 ± 0.34

0.110

0.057

150

0.83 ± 0.34

0.81 ± 0.43

0.80 ± 0.36

0.777

0.004

191

0.87 ± 0.65

0.66 ± 0.62

0.59 ± 0.48

0.017

0.073

197

1.13 ± 0.68

0.97 ± 0.82

0.82 ± 0.45

0.019

0.072

223

0.93 ± 0.55

0.78 ± 0.50

0.70 ± 0.41

0.014

0.076

320

0.93 ± 0.46

0.82 ± 0.46

0.79 ± 0.40

0.087

0.045

451a

1.04 ± 0.65

0.95 ± 0.43

1.20 ± 0.99

0.165

0.034

486

0.96 ± 0.70

0.85 ± 0.45

1.11 ± 1.17

0.215

0.028